A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

WASHINGTON–A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 ...

Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, ...

While death rates from cardiovascular disease have declined 60% since 1950, a recent upward trend aligns with increases in ...

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early ...

Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone ...

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Patients that receive virtual cardiac rehabilitation have improved hospital admission and emergency department visit rates.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at exploring immune-related genes and their expression changes in myocardial ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon emission ...